Search / Trial NCT06225089

Effect of Pericapsular Nerve Block on the Quality of Recovery After Shoulder Arthroscopy

Launched by KONYA CITY HOSPITAL · Jan 17, 2024

Trial Information

Current as of October 03, 2024

Completed

Keywords

Description

Shoulder arthroscopy surgery is one of the most common orthopedic surgical procedures. Participants experience severe pain after shoulder arthroscopy surgery. This causes the use of high amounts of opioids, delays healing, causes bleeding in the surgical area, and can cause physiological disorders by increasing the stress response. Multiple studies have been conducted for analgesic purposes in shoulder surgery. The axillary nerve is said to supply nerves to the inferior part of the suprascapular nerve, the posterior inferior part of the posterior branch of the axillary nerve, and the anteri...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Patients who will have unilateral shoulder arthroscopy
  • * Patients who will receive general anesthesia
  • * Patients aged 18-65
  • * Patients with ASAI-III
  • * in the hospital for at least 24 hours postoperatively
  • Exclusion Criteria:
  • * Patients who do not want to give consent
  • * Patients for whom regional anesthesia is contraindicated
  • * Patients with ASA IV and above
  • * Patients with confusion
  • * Patients with a bad bleeding profile using anticoagulants
  • * Patients with infection in the area to be treated
  • * Emergency cases

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Konya, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0